Form 4: Teradyne CEO Sells Shares Under 10b5-1 Plan

Teradyne's President and CEO, Gregory Stephen Smith, sold 554 shares of common stock for $126.39 per share under a pre-arranged 10b5-1 trading plan.

Summary

• Gregory Stephen Smith, President and CEO of Teradyne, Inc. (TER), reported a sale of common stock.
• The transaction involved the disposition of 554 shares of Teradyne common stock.
• The shares were sold at a price of $126.39 per share.
• The sale occurred on September 22, 2025.
• Following this transaction, Gregory Stephen Smith beneficially owns 95,884.995 shares of common stock directly.
• The sale was executed pursuant to a Rule 10b5-1 sales plan adopted by Mr. Smith on February 4, 2025.

Sentiment

Score: 6

Explanation: The sale of shares by the CEO, while a disposition, was conducted under a pre-established Rule 10b5-1 trading plan. This indicates a planned personal financial management strategy rather than a reaction to new, adverse company developments, thus making the sentiment relatively neutral to slightly positive due to transparency.

Positives

• The sale was conducted under a Rule 10b5-1 plan, indicating a pre-scheduled transaction for personal financial management rather than a reaction to new, negative company information.

Negatives

• An insider sale, even under a 10b5-1 plan, can sometimes be perceived by the market as a lack of confidence, though this is mitigated by the pre-planned nature.

Future Outlook

NA

Management Comments

• The sale of shares by Gregory Stephen Smith was executed under a pre-arranged Rule 10b5-1 trading plan, established on February 4, 2025, to ensure compliance with insider trading regulations.

Industry Context

This Form 4 filing reports a routine insider transaction and does not provide information relevant to broader industry trends or competitive analysis.

Stakeholder Impact

• Shareholders: May observe the insider sale, but the 10b5-1 plan generally reduces concerns about management's confidence in the company's future.

Key Dates

Recommendation

This Form 4 filing reports a routine, pre-planned insider sale of a relatively small number of shares by the CEO under a Rule 10b5-1 plan. Such a transaction is generally considered neutral and does not provide sufficient new information to warrant a change in investment recommendation for Teradyne, Inc. Investors should continue to hold based on broader company fundamentals and market conditions.

Keywords

Teradyne, TER, Insider Trading, Form 4, Stock Sale, Gregory Stephen Smith, 10b5-1 Plan, CEO, Director